203 related articles for article (PubMed ID: 15183629)
1. The nicotinic acid receptor--a new mechanism for an old drug.
Karpe F; Frayn KN
Lancet; 2004 Jun; 363(9424):1892-4. PubMed ID: 15183629
[TBL] [Abstract][Full Text] [Related]
2. Continuous 24-h nicotinic acid infusion in rats causes FFA rebound and insulin resistance by altering gene expression and basal lipolysis in adipose tissue.
Oh YT; Oh KS; Choi YM; Jokiaho A; Donovan C; Choi S; Kang I; Youn JH
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1012-21. PubMed ID: 21386057
[TBL] [Abstract][Full Text] [Related]
3. PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect.
Tunaru S; Kero J; Schaub A; Wufka C; Blaukat A; Pfeffer K; Offermanns S
Nat Med; 2003 Mar; 9(3):352-5. PubMed ID: 12563315
[TBL] [Abstract][Full Text] [Related]
4. Niacin stimulates adiponectin secretion through the GPR109A receptor.
Plaisance EP; Lukasova M; Offermanns S; Zhang Y; Cao G; Judd RL
Am J Physiol Endocrinol Metab; 2009 Mar; 296(3):E549-58. PubMed ID: 19141678
[TBL] [Abstract][Full Text] [Related]
5. Antilipolytic activity of a novel partial A1 adenosine receptor agonist devoid of cardiovascular effects: comparison with nicotinic acid.
Dhalla AK; Santikul M; Smith M; Wong MY; Shryock JC; Belardinelli L
J Pharmacol Exp Ther; 2007 Apr; 321(1):327-33. PubMed ID: 17204748
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials.
Lukasova M; Hanson J; Tunaru S; Offermanns S
Trends Pharmacol Sci; 2011 Dec; 32(12):700-7. PubMed ID: 21944259
[TBL] [Abstract][Full Text] [Related]
7. Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review.
Carlson LA
J Intern Med; 2005 Aug; 258(2):94-114. PubMed ID: 16018787
[TBL] [Abstract][Full Text] [Related]
8. [Nicotinic acid and derivatives for therapy of hyperlipoproteinemia].
Ishikawa T
Nihon Rinsho; 1994 Dec; 52(12):3292-7. PubMed ID: 7853725
[TBL] [Abstract][Full Text] [Related]
9. The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target.
Offermanns S
Trends Pharmacol Sci; 2006 Jul; 27(7):384-90. PubMed ID: 16766048
[TBL] [Abstract][Full Text] [Related]
10. Adipose Tissue Free Fatty Acid Storage In Vivo: Effects of Insulin Versus Niacin as a Control for Suppression of Lipolysis.
Ali AH; Mundi M; Koutsari C; Bernlohr DA; Jensen MD
Diabetes; 2015 Aug; 64(8):2828-35. PubMed ID: 25883112
[TBL] [Abstract][Full Text] [Related]
11. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia.
Julius U
Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids and the risk of death during acute myocardial ischaemia.
Oliver MF
Clin Sci (Lond); 2015 Mar; 128(6):349-55. PubMed ID: 25456320
[TBL] [Abstract][Full Text] [Related]
13. The high-fat high-fructose hamster as an animal model for niacin's biological activities in humans.
Connolly BA; O'Connell DP; Lamon-Fava S; LeBlanc DF; Kuang YL; Schaefer EJ; Coppage AL; Benedict CR; Kiritsy CP; Bachovchin WW
Metabolism; 2013 Dec; 62(12):1840-9. PubMed ID: 24035454
[TBL] [Abstract][Full Text] [Related]
14. Comparison of rat and dog models of vasodilatation and lipolysis for the calculation of a therapeutic index for GPR109A agonists.
Carballo-Jane E; Gerckens LS; Luell S; Parlapiano AS; Wolff M; Colletti SL; Tata JR; Taggart AK; Waters MG; Richman JG; McCann ME; Forrest MJ
J Pharmacol Toxicol Methods; 2007; 56(3):308-16. PubMed ID: 17643322
[TBL] [Abstract][Full Text] [Related]
15. On the suppression of plasma nonesterified fatty acids by insulin during enhanced intravascular lipolysis in humans.
Carpentier AC; Frisch F; Cyr D; Généreux P; Patterson BW; Giguère R; Baillargeon JP
Am J Physiol Endocrinol Metab; 2005 Nov; 289(5):E849-56. PubMed ID: 15972273
[TBL] [Abstract][Full Text] [Related]
16. Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?
Pike NB; Wise A
Curr Opin Investig Drugs; 2004 Mar; 5(3):271-5. PubMed ID: 15083592
[TBL] [Abstract][Full Text] [Related]
17. Effects of nicotinic acid on gene expression: potential mechanisms and implications for wanted and unwanted effects of the lipid-lowering drug.
Kang I; Kim SW; Youn JH
J Clin Endocrinol Metab; 2011 Oct; 96(10):3048-55. PubMed ID: 21816780
[TBL] [Abstract][Full Text] [Related]
18. New evidence for nicotinic acid treatment to reduce atherosclerosis.
Montecucco F; Quercioli A; Dallegri F; Viviani GL; Mach F
Expert Rev Cardiovasc Ther; 2010 Oct; 8(10):1457-67. PubMed ID: 20936932
[TBL] [Abstract][Full Text] [Related]
19. Regional difference in insulin inhibition of non-esterified fatty acid release from human adipocytes: relation to insulin receptor phosphorylation and intracellular signalling through the insulin receptor substrate-1 pathway.
Zierath JR; Livingston JN; Thörne A; Bolinder J; Reynisdottir S; Lönnqvist F; Arner P
Diabetologia; 1998 Nov; 41(11):1343-54. PubMed ID: 9833943
[TBL] [Abstract][Full Text] [Related]
20. Free fatty acids and insulin resistance.
Delarue J; Magnan C
Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):142-8. PubMed ID: 17285001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
